Clinical Significance of Molecular Expression Profiles of Hürthle Cell Tumors of the Thyroid Gland Analyzed via Tissue Microarrays
- 31 January 2002
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 160 (1), 175-183
- https://doi.org/10.1016/s0002-9440(10)64361-1
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- DNA damage-induced phosphorylation of p53 at serine 20 correlates with p21 and Mdm-2 induction in vivoOncogene, 2000
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998
- TUMOR CELL PROLIFERATION AND SURVIVAL IN PATIENTS WITH PROSTATE CANCER FOLLOWED EXPECTANTLYJournal of Urology, 1998
- BCL-2 FAMILY: Regulators of Cell DeathAnnual Review of Immunology, 1998
- Ki-67 immunostaining in 322 primary breast cancers: Associations with clinical and pathological variables and prognosisInternational Journal of Cancer, 1997
- Poorly Differentiated Oxyphilic (Hurthle Cell) Carcinomas of the ThyroidThe American Journal of Surgical Pathology, 1996
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivationCell, 1992
- The p53 tumour suppressor geneNature, 1991
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958